Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]

Immunotherapy of T-ALL: Opportunities and hurdles

Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA

Immunotherapy of T-ALL: Opportunities and hurdles ( Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA )

Triple class refractory multiple myeloma

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...

$Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )$

Managing immune-related adverse effects in Africa

Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya

Managing immune-related adverse effects in Africa ( Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya )

Palliative care in Africa

Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation...

Palliative care in Africa ( Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation, Kigali City, Rwanda )

Managing high-risk/MRD positive and standard-risk/MRD myeloma

Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy

Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )

Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma

Prof Wee Joo Chng - National University Cancer Institute, Singapore

Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng - National University Cancer Institute, Singapore )

Rescue after daratumumab failure

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...

Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )

OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Advances in prostate cancer in the last 10 years and a glimpse to the future

Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono

Advances in prostate cancer in the last 10 years and a glimpse to the future ( Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono )

WCLC 2021: Epidemiology of MET Exon 14 mutations

Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht...

WCLC 2021: Epidemiology of MET Exon 14 mutations ( Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger )

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Refractoriness and retreatment in the era of lenalidomide and mABs in the...

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway

$Refractoriness and retreatment in the era of lenalidomide and mABs in the frontline myeloma setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )$

More from ecancer